State of the Art and Next Questions: Aggressive B-Cell Lymphomas

SOHO Highlights: State of the Art and Next Questions

G. Nowakowski

Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…

Daniel Addison

CLL/SLL: Outcomes of Pts With Richter's Transformation Without Prior…

Insights from 2023 ASH Annual Meeting

A. Kittai

ASCO® 2024 Insights: "TRANSFORM Study - 3-Year Follow-Up Comparing L…

2024 ASCO® Annual Meeting Insights Hub

M. Kamdar

Updates on Cellular Therapy Advances in Lymphoma

Yale Cancer Center

I. Isufi

Special Considerations in Adolescent and Young Adult Patients: Insig…

UChicago Medicine

A. LaCasce

SOHO 2023: Treatment Options for Primary Mediastinal B-Cell Lymphoma

SOHO 2023 Eleventh Annual Meeting

K. Dunleavy

ASH 2023 Insights: "Efficacy of Mosunetuzumab Monotherapy in Patient…

Insights from 2023 ASH Annual Meeting

C. Cheah

SOHO Turkey 2023: DLBCL Management

SOHO Turkey 2023

I. Barista

ASCO® 2023 Insights: "Observation Vs. Radiotherapy in Primary Medias…

ecancer

E. Zucca

EHA 2024 Insights: Axicabtagene Ciloleucel in R/R Primary Mediastina…

Insights from 2024 EHA Annual Meeting

J. Galtier

ASCO® 2023 Insights: "The Phase 2 KEYNOTE-B68 Trial - Efficacy & Saf…

Insights from 2023 ASCO® Annual Meeting

A. Mcdonald

ASH 2023 Insights: "Anti-CD19 CAR T-Cell Therapy for Richter's Trans…

Insights from 2023 ASH Annual Meeting

A. Kittai

ASCO® 2023 Insights: "ZUMA-7 Study Summary - Axi-Cel in Early R/R La…

ecancer

J. Westin

UChicago Medicine Lymphoma Updates: Experts Review the Session on th…

UChicago Medicine

S. Smith, T. Fenske, A. Evens

SOHO Highlights - State of the Art & Next Questions: Aggressive B-Ce…

SOHO Highlights: State of the Art and Next Questions

L. Sehn

ASCO 2022 PACIFIC Trial Updates: Response Kinetics, Safety & Efficac…

ASCO 2022 Conference Coverage

R. Steiner

SOHO 2022: Challenging Cases in Rare T-Cell Lymphomas

SOHO 2022 Tenth Annual Meeting

S. Barta

VCU Health Updates on Extranodal Lymphomas

VCU Massey Cancer Center

V. Yazbeck

ESMO 2021 Highlights on Lymphomas: R/R Marginal Zone Lymphoma, PMLBC…

2021 Virtual ESMO Review

J. Vose